comparemela.com

Latest Breaking News On - கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் இணை - Page 28 : comparemela.com

Locust Walk Acquisition Corp Class A Common Shares and Warrants to Commence Trading Separately on March 1, 2021

Share this article Share this article PHILADELPHIA and BOSTON, Feb. 22, 2021 /PRNewswire/ Locust Walk Acquisition Corp. (NASDAQ: LWACU) (the Company ), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that the holders of the Company s units may elect to separately trade the Class A common shares and warrants underlying the units commencing on March 1, 2021. Those units not separated will continue to trade on the NASDAQ Capital Market under the symbol LWACU and the Class A common shares and warrants are expected to trade under the symbols LWAC and LWACW , respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

AmTrust CEO-backed SPAC files for $300 million IPO

By Reuters Staff 2 Min Read (Reuters) - A blank-check firm, backed by AmTrust Financial Services Chief Executive Officer Barry Zyskind, is looking to raise $300 million through an initial public offering, a regulatory filing showed on Friday. Pine Technology Acquisition Corp said it plans to sell 30 million units, made up of shares and warrants, priced at $10 per share on the Nasdaq Capital Market. (bit.ly/37tIFJz) The special purpose acquisition company (SPAC), founded by current and former senior executives of New York City-based insurer AmTrust, plans to look for targets in the so-called insurance technology, or “insurtech” sector. The COVID-19 pandemic has increased the insurance sector’s reliance on technology to reach customers, putting the focus on companies such as Lemonade Inc.

SPAC Backed by AmTrust Executives Files for $300M IPO

AmTrust CEO-backed SPAC files for $300 million IPO

AmTrust CEO-backed SPAC files for $300 million IPO
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Protein sequencing firm Quantum-Si to go public via $1 46 billion SPAC merger

By Reuters Staff 2 Min Read (Reuters) - Chip-based protein sequencing firm Quantum-Si Incorporated has agreed to go public through a merger with blank-check firm HighCape Capital Acquisition Corp in a deal that values the combined company at $1.46 billion. The deal will be financed through a private investment of $425 million from institutional investors such as Foresite Capital Management LLC, Eldridge, and Glenview Capital Management LLC, the companies said on Thursday. Guilford, Connecticut-based Quantum-Si operates a platform that uses semiconductor chips to decode proteins. It offers tools for sample preparation, sequencing and data analysis. HighCape, a special purpose acquisition company (SPAC), raised $115 million in its initial public offering in September. SPACs are shell companies that raise funds through an IPO to acquire a private company, which becomes public as a result.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.